Presentation is loading. Please wait.

Presentation is loading. Please wait.

A New KIT Gene Mutation in Thymic Cancer and a Promising Response to Imatinib  Sung Hee Lim, MD, Ji-Yun Lee, MD, Jong-Mu Sun, MD, PhD, Kyoung-Mee Kim,

Published byChloe Douglas Modified over 5 years ago

Similar presentations

Presentation on theme: "A New KIT Gene Mutation in Thymic Cancer and a Promising Response to Imatinib  Sung Hee Lim, MD, Ji-Yun Lee, MD, Jong-Mu Sun, MD, PhD, Kyoung-Mee Kim,"— Presentation transcript:

1 A New KIT Gene Mutation in Thymic Cancer and a Promising Response to Imatinib 
Sung Hee Lim, MD, Ji-Yun Lee, MD, Jong-Mu Sun, MD, PhD, Kyoung-Mee Kim, MD, PhD, Jin Seok Ahn, MD, PhD, Myung-Ju Ahn, MD, PhD, Keunchil Park, MD, PhD  Journal of Thoracic Oncology  Volume 8, Issue 10, Pages e91-e92 (October 2013) DOI: /JTO.0b013e31829d51bd Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

2 FIGURE 1 Thymic carcinoma in a patient with an activating KIT mutation before treatment with imatinib: hematoxylin and eosin (×400) (A), immunohistochemical KIT staining (×400) (B). Journal of Thoracic Oncology 2013 8, e91-e92DOI: ( /JTO.0b013e31829d51bd) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

3 FIGURE 2 Chest CT images at baseline and after 15 months of imatinib treatment showed a decrease in size with cystic change of the anterior mediastinal mass (A); the right pleural-based mass had nearly disappeared and pleural effusion decreased (B). Positron emission tomography–CT scans at the same time points also showed decreased FDG uptake in the corresponding lesions of the anterior mediastinum (C) and pleura (D). CT, computed tomography; FDG, fluorodeoxyglucose. Journal of Thoracic Oncology 2013 8, e91-e92DOI: ( /JTO.0b013e31829d51bd) Copyright © 2013 International Association for the Study of Lung Cancer Terms and Conditions

Download ppt "A New KIT Gene Mutation in Thymic Cancer and a Promising Response to Imatinib  Sung Hee Lim, MD, Ji-Yun Lee, MD, Jong-Mu Sun, MD, PhD, Kyoung-Mee Kim,"

Similar presentations

Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non–Small Cell Lung Cancer  Haa-Na Song, MD,

Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non–Small Cell Lung Cancer  Haa-Na Song, MD,
Neoplastic Fever Caused by Lung Cancer

Neoplastic Fever Caused by Lung Cancer
A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab  Monica Khunger, MD  Journal of Thoracic.

A Case of a Patient with Idiopathic Pulmonary Fibrosis with Lung Squamous Cell Carcinoma Treated with Nivolumab  Monica Khunger, MD  Journal of Thoracic.
Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non– Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor.

Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non– Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor.
Clinical Value of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Differentiation of Malignant Mesothelioma from Asbestos-Related.

Clinical Value of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Differentiation of Malignant Mesothelioma from Asbestos-Related.
Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection.

Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection.
Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 

Hironori Yoshida, MD, Young Hak Kim, MD  Journal of Thoracic Oncology 
Two Cases of Small Cell Lung Cancer Transformation from EGFR Mutant Adenocarcinoma During AZD9291 Treatment  Jun Soo Ham, MD, Seokhwi Kim, MD, Hee Kyung.

Two Cases of Small Cell Lung Cancer Transformation from EGFR Mutant Adenocarcinoma During AZD9291 Treatment  Jun Soo Ham, MD, Seokhwi Kim, MD, Hee Kyung.
Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.
Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection.

Who Are Less Likely to Receive Subsequent Chemotherapy Beyond First-Line Therapy for Advanced Non-small Cell Lung Cancer?: Implications for Selection.
Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.

Malignant Pleural Mesothelioma Harboring Both G719C and S768I Mutations of EGFR Successfully Treated with Afatinib  Nobukazu Agatsuma, MD  Journal of.
Paraneoplastic Opsoclonus-Myoclonus Syndrome as a New and Single Manifestation of Relapsing Disease in a Patient with Small Cell Lung Cancer  Ernest Nadal,

Paraneoplastic Opsoclonus-Myoclonus Syndrome as a New and Single Manifestation of Relapsing Disease in a Patient with Small Cell Lung Cancer  Ernest Nadal,
Y-L Chang, MD, C-T Wu, MD, Y-C Lee, MD, PhD 

Y-L Chang, MD, C-T Wu, MD, Y-C Lee, MD, PhD 
Rapid Acquisition of T790M Mutation after Treatment with Afatinib in an NSCLC Patient Harboring EGFR Exon 20 S768I Mutation  Alessandro Russo, MD, Tindara.

Rapid Acquisition of T790M Mutation after Treatment with Afatinib in an NSCLC Patient Harboring EGFR Exon 20 S768I Mutation  Alessandro Russo, MD, Tindara.
Thymic Hyperplasia after Treatment of ACTH-Dependent Cushing’s Syndrome Can Be Mistaken for a Thymic Epithelial Tumor  Jaydira Del Rivero, MD, Chul Kim,

Thymic Hyperplasia after Treatment of ACTH-Dependent Cushing’s Syndrome Can Be Mistaken for a Thymic Epithelial Tumor  Jaydira Del Rivero, MD, Chul Kim,
Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non–Small Cell Lung Cancer  Haa-Na Song, MD,

Acquired C797S Mutation upon Treatment with a T790M-Specific Third-Generation EGFR Inhibitor (HM61713) in Non–Small Cell Lung Cancer  Haa-Na Song, MD,
A Case of Concurrent De Novo C797S and L858R EGFR Mutation Detected in Stage IA Non–Small Cell Lung Cancer Patient  Jong Sik Lee, MD, Jae Young Hur, PhD,

A Case of Concurrent De Novo C797S and L858R EGFR Mutation Detected in Stage IA Non–Small Cell Lung Cancer Patient  Jong Sik Lee, MD, Jae Young Hur, PhD,
Cholesterol Granuloma: A Rare Benign Rib Tumor

Cholesterol Granuloma: A Rare Benign Rib Tumor
Immunoglobulin G4–Related Periaortitis Involving the Aortic Arch Mimicking a Mediastinal Tumor  Min Jae Cha, MD, Semin Chong, MD, Yang Soo Kim, MD, Byungjoon.

Immunoglobulin G4–Related Periaortitis Involving the Aortic Arch Mimicking a Mediastinal Tumor  Min Jae Cha, MD, Semin Chong, MD, Yang Soo Kim, MD, Byungjoon.
Surgically Resected Isolated Hepatic Metastasis from Non-small Cell Lung Cancer: A Case Report  Kyu-Sik Kim, Kook-Joo Na, Yun-Hyeon Kim, Sung-Ja Ahn,

Surgically Resected Isolated Hepatic Metastasis from Non-small Cell Lung Cancer: A Case Report  Kyu-Sik Kim, Kook-Joo Na, Yun-Hyeon Kim, Sung-Ja Ahn,

Similar presentations

Ads by Google